Fig. 7From: Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathwayMechanism exploration of TGFBI functions 1. A Proteomic analysis of the pathway enrichment in the TGFBI KO SKOV-3 cell line compared to the control cell line. B WB analysis of the phosphorylation levels of PI3K and Akt in TGFBI KO cell lines compared to the control ones. C, D WB analysis of TGFBI EO cell lines after treatment with broad integrin inhibitor (MK-0429). KO knock out, EO over-expression. *p < 0.05, **p < 0.01, ***p < 0.001Back to article page